– USA, CA – Dalrada Corporation (OTC: DFCO), an innovator in clean energy, healthcare, and technology, today announced the appointment of Nick Gordon to its Board of Directors, bringing vast expertise in real estate investments trusts, real estate development, and capital growth.
“Nick’s deep knowledge of the real estate and commercial business sectors greatly increases Dalrada’s ability to expand our footprint in numerous market verticals, including clean energy adoption by the hospitality industry and commercial property sector. I’m excited to work with Nick, and I welcome him to our Board of Directors,” said Chairman and CEO, Brian Bonar.
About Nick Gordon
Mr. Gordon is SVP of Institutional Investments at Millennium Commercial Properties. Mr. Gordon co-founded the real estate development and overseas trading companies Empire Commercial and Empire Trading International. He previously held positions as Managing Director of Forstmann & Co. and co-founded numerous companies, including Global Trust Group, a boutique private equity firm, and AMP Medical products. During his nearly 20-year career in sales and management, he has received numerous awards working for multi-billion-dollar companies like Eli Lilly, Medicis, Johnson & Johnson, and Mallinckrodt.
About Dalrada
Dalrada drives innovation that positively impacts people, businesses, and the planet. With subsidiaries that are firmly positioned in the world’s top three-growing industries of healthcare, clean energy, and technology, Dalrada creates solutions that are sustainable, affordable, and accessible.
The company works continually to produce disruptive products and services that accelerate positive change for current and future generations. Dalrada’s global solutions directly address climate change, post-pandemic gaps in the healthcare industry, and technology solutions for a new era of human behavior and interaction, ensuring a bright future for the world around us.
Established in 1982, Dalrada has since grown its footprint to include the unique business divisions: Dalrada Health, Dalrada Precision, and Dalrada Technologies.
For more information: https://dalrada.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.